Hiroyuki Nakamura – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
18 produkter
18 produkter
Inbunden, Engelska, 2015
1 107 kr
Skickas inom 10-15 vardagar
From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.
E-bok
PDF, Engelska, 20151 292 kr
Läs direkt efter köp
From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.
Häftad, Engelska, 2016
997 kr
Skickas inom 10-15 vardagar
From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.
Inbunden, Engelska, 2016
1 876 kr
Skickas inom 10-15 vardagar
This book considers chronic obstructive pulmonary disease (COPD) not as a simple inflammation of the lung but as a systemic inflammatory disease. Beginning with epidemiological studies, etiology, diagnosis and treatment, it elaborates further, illustrating some comorbidities and associations with other respiratory diseases. As such it provides numerous improved and more comprehensive treatment methods, including drug therapies as well as some non-drug therapies. There are also chapters describing the pathogenesis, genetic abnormalities and newly discovered pathogenetic mechanisms that are expected to be studied further in the future.Edited and written by pioneering researchers, each chapter summarizes the latest trends, describes future prospects and explores the unresolved and critical questions. Chronic Obstructive Pulmonary Disease - A Systemic Inflammatory Disease is a valuable resource to beginning researchers, physicians engaged in clinical practice, supervisors, and basic researchers whose work includes COPD.
E-bok
Engelska, 20162 430 kr
Läs direkt efter köp
This book considers chronic obstructive pulmonary disease (COPD) not as a simple inflammation of the lung but as a systemic inflammatory disease. Beginning with epidemiological studies, etiology, diagnosis and treatment, it elaborates further, illustrating some comorbidities and associations with other respiratory diseases. As such it provides numerous improved and more comprehensive treatment methods, including drug therapies as well as some non-drug therapies. There are also chapters describing the pathogenesis, genetic abnormalities and newly discovered pathogenetic mechanisms that are expected to be studied further in the future.Edited and written by pioneering researchers, each chapter summarizes the latest trends, describes future prospects and explores the unresolved and critical questions. Chronic Obstructive Pulmonary Disease - A Systemic Inflammatory Disease is a valuable resource to beginning researchers, physicians engaged in clinical practice, supervisors, and basic researchers whose work includes COPD.
Inbunden, Engelska, 2017
1 107 kr
Skickas inom 10-15 vardagar
This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.
E-bok
Engelska, 20171 455 kr
Läs direkt efter köp
This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.
Häftad, Engelska, 2018
1 876 kr
Skickas inom 10-15 vardagar
This book considers chronic obstructive pulmonary disease (COPD) not as a simple inflammation of the lung but as a systemic inflammatory disease. Beginning with epidemiological studies, etiology, diagnosis and treatment, it elaborates further, illustrating some comorbidities and associations with other respiratory diseases. As such it provides numerous improved and more comprehensive treatment methods, including drug therapies as well as some non-drug therapies. There are also chapters describing the pathogenesis, genetic abnormalities and newly discovered pathogenetic mechanisms that are expected to be studied further in the future.Edited and written by pioneering researchers, each chapter summarizes the latest trends, describes future prospects and explores the unresolved and critical questions. Chronic Obstructive Pulmonary Disease - A Systemic Inflammatory Disease is a valuable resource to beginning researchers, physicians engaged in clinical practice, supervisors, and basic researchers whose work includes COPD.
Häftad, Engelska, 2019
1 107 kr
Skickas inom 10-15 vardagar
This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.
Inbunden, Engelska, 2020
1 107 kr
Skickas inom 10-15 vardagar
This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.
E-bok
Engelska, 20201 292 kr
Läs direkt efter köp
This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management.
The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.
Häftad, Engelska, 2021
997 kr
Skickas inom 10-15 vardagar
This book provides up-to-date guidance on the use of FDG PET to assess the biological activity and treatment response of a wide range of malignancies, including, for example, lung cancer, breast cancer, head and neck cancer, gastrointestinal cancer, and malignant lymphoma. In the era of precision medicine, numerous new anticancer agents, such as molecular targeted agents and immune checkpoint inhibitors, have been developed to improve outcomes in cancer patients. FDG PET plays a key role in evaluating the effects of these novel treatments because it can detect changes in the metabolic activity of tumors before any reduction in their size is visible on other imaging modalities. Accordingly, FDG PET is of prognostic as well as diagnostic value, and allows prompt changes in patient management. The book is written by expert clinicians from Japan, where the universal public health insurance system ensures that FDG PET is widely used in routine oncological practice and cancer screening. It represents an unrivaled and comprehensive resource that will be of value for all healthcare professionals in the field of clinical oncology.
Inbunden, Engelska, 2026
2 385 kr
Kommande
This book includes the selected papers from the 9th International Conference on Nanomaterials and Biomaterials (ICNB 2025), which offers a comprehensive compilation of cutting-edge research and innovation in the interdisciplinary fields of nanotechnology and biomaterials. With a diverse range of contributions from leading experts and researchers globally, this book delves into fundamental and applied aspects of nanomaterials and their integration into biomedical applications, including drug delivery, tissue engineering, and regenerative medicine. This book serves as a pivotal platform for fostering collaboration and knowledge exchange among academia, industry, and healthcare sectors, addressing current challenges and opportunities in the field. Readers encounter a wealth of insights through peer-reviewed articles that emphasize novel material synthesis, characterization methods, and real-world applications. This book highlights the importance of sustainable and biocompatible materials in enhancing patient outcomes and exploring the future potential of nanotechnology in healthcare.
Inbunden, Engelska, 2025
1 436 kr
Skickas inom 10-15 vardagar
This book presents the latest research on speech biomarkers and demonstrates the benefits of quantitative measurement technology for emotion and stress in clinical settings. It begins with an introduction and details the validation of a technique for assessing emotions using voice biomarkers. This technology evaluates stress levels, which affect emotional expression and lead to changes in certain voice qualities. It further explains how a voice emotion recognition system can effectively detect illnesses such as anxiety disorders, depression, bipolar disorder, PTSD, Parkinson’s disease, dementia, and more. Beyond clinical applications, it is also useful for the mental care of athletes and assessing driving skills. Voice biomarkers can be easily, non-invasively, and remotely measured, offering excellent cost efficiency. This book lays the groundwork for addressing unresolved issues and advancing further."Voice Biomarkers - Current Status and Issues in the Development" is an invaluable resource for healthcare professionals at all levels, especially those involved in pathophysiology, disaster psychology, mental health, and social medicine. Researchers in engineering will also find this book insightful.
E-bok
Engelska, 20251 780 kr
Läs direkt efter köp
This book presents the latest research on speech biomarkers and demonstrates the benefits of quantitative measurement technology for emotion and stress in clinical settings. It begins with an introduction and details the validation of a technique for assessing emotions using voice biomarkers. This technology evaluates stress levels, which affect emotional expression and lead to changes in certain voice qualities. It further explains how a voice emotion recognition system can effectively detect illnesses such as anxiety disorders, depression, bipolar disorder, PTSD, Parkinson’s disease, dementia, and more. Beyond clinical applications, it is also useful for the mental care of athletes and assessing driving skills. Voice biomarkers can be easily, non-invasively, and remotely measured, offering excellent cost efficiency. This book lays the groundwork for addressing unresolved issues and advancing further.
"Voice Biomarkers - Current Status and Issues in the Development" is an invaluable resource for healthcare professionals at all levels, especially those involved in pathophysiology, disaster psychology, mental health, and social medicine. Researchers in engineering will also find this book insightful.
Häftad, Engelska, 2026
1 107 kr
Skickas inom 10-15 vardagar
This book presents the latest research on speech biomarkers and demonstrates the benefits of quantitative measurement technology for emotion and stress in clinical settings. It begins with an introduction and details the validation of a technique for assessing emotions using voice biomarkers. This technology evaluates stress levels, which affect emotional expression and lead to changes in certain voice qualities. It further explains how a voice emotion recognition system can effectively detect illnesses such as anxiety disorders, depression, bipolar disorder, PTSD, Parkinson’s disease, dementia, and more. Beyond clinical applications, it is also useful for the mental care of athletes and assessing driving skills. Voice biomarkers can be easily, non-invasively, and remotely measured, offering excellent cost efficiency. This book lays the groundwork for addressing unresolved issues and advancing further."Voice Biomarkers - Current Status and Issues in the Development" is an invaluable resource for healthcare professionals at all levels, especially those involved in pathophysiology, disaster psychology, mental health, and social medicine. Researchers in engineering will also find this book insightful.
Inbunden, Engelska, 2025
1 107 kr
Skickas inom 10-15 vardagar
This book provides an in-depth look into the transformative world of AI Surgery, offering a detailed examination of its recent advances and future potential. Beginning with a clear definition and classification of "AI Surgery," the book sets the stage for understanding how artificial intelligence is reshaping surgical practices. It addresses the pressing need for data standardization and cybersecurity, crucial for the effective implementation of AI in medical environments.The chapters cover a wide range of topics, including the development of Smart Cyber Operating Theaters and the intricacies of surgical process and semantic data modeling. The book also tackles regulatory and ethical issues, providing a comprehensive overview of the challenges faced by AI Surgery. Real-world clinical cases in neurosurgery, orthopedic surgery, eye surgery, and laparoscopic surgery illustrate the practical applications of AI, while future trends such as AI-driven robotics, telesurgery using 5G, and AI-enhanced theranostics are explored in detail.Readers will find contributions from leading experts in the field, offering diverse perspectives and insights. The book invites readers to consider critical questions about the future of surgery and the role of AI in enhancing surgical outcomes. It is a vital resource for medical engineers, AI researchers, and medical doctors interested in cutting-edge medical technologies. It serves as a foundation for future advancements in AI Surgery, making it an essential read for professionals seeking to understand and contribute to the future of surgical innovation.
E-bok
Engelska, 20251 455 kr
Läs direkt efter köp
This book provides an in-depth look into the transformative world of AI Surgery, offering a detailed examination of its recent advances and future potential. Beginning with a clear definition and classification of "e;AI Surgery,"e; the book sets the stage for understanding how artificial intelligence is reshaping surgical practices. It addresses the pressing need for data standardization and cybersecurity, crucial for the effective implementation of AI in medical environments.The chapters cover a wide range of topics, including the development of Smart Cyber Operating Theaters and the intricacies of surgical process and semantic data modeling. The book also tackles regulatory and ethical issues, providing a comprehensive overview of the challenges faced by AI Surgery. Real-world clinical cases in neurosurgery, orthopedic surgery, eye surgery, and laparoscopic surgery illustrate the practical applications of AI, while future trends such as AI-driven robotics, telesurgery using 5G, and AI-enhanced theranostics are explored in detail.Readers will find contributions from leading experts in the field, offering diverse perspectives and insights. The book invites readers to consider critical questions about the future of surgery and the role of AI in enhancing surgical outcomes. It is a vital resource for medical engineers, AI researchers, and medical doctors interested in cutting-edge medical technologies. It serves as a foundation for future advancements in AI Surgery, making it an essential read for professionals seeking to understand and contribute to the future of surgical innovation.